Old Web
English
Sign In
Acemap
>
authorDetail
>
Mary Birmingham
Mary Birmingham
Janssen Pharmaceutica
Medicine
Emergency medicine
Randomized controlled trial
Renal function
Atrial fibrillation
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of a Centralized, Blended Electronic and Human Intervention to Improve Direct Oral Anticoagulant Adherence: Smartphones to improve rivaroxaban ADHEREnce in Atrial Fibrillation (SmartADHERE) A Randomized Clinical Trial: SmartADHERE rivaroxaban adherence trial.
2021
American Heart Journal
Mintu P. Turakhia
Vandana Sundaram
Shea N. Smith
Victoria Y. Ding
P. Michael Ho
Peter R. Kowey
Jonathan P. Piccini
JoAnne Foody
Mary Birmingham
Juliana Ianus
Amol Rajmane
Kenneth W. Mahaffey
Show All
Source
Cite
Save
Citations (0)
Novel Trial Design: CHIEF-HF.
2021
Circulation-heart Failure
John A. Spertus
Mary Birmingham
Javed Butler
Ildiko Lingvay
David E. Lanfear
Antonio Abbate
Mikhail Kosiborod
Christina Fawcett
Paul Burton
C.V. Damaraju
James L. Januzzi
John Whang
Show All
Source
Cite
Save
Citations (2)
ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS
2019
Journal of the American College of Cardiology
Michael Dorsch
Sean Pokorney
Mary Birmingham
John A. House
Kenneth Todd Moore
Bobbie James
Sue Mashni
Kevin Thomas
Kevin Anstrom
Gerald Naccarelli
Peter Berger
Gregory Fermann
Christopher B. Granger
Elaine Hylek
Show All
Source
Cite
Save
Citations (2)
1